Respi helps Asthmatic and COPD patients live a healthy life with a management based on the patient’s smartphone. It consists of a smartphone enabled spirometer and a connected mobile app that offers disease monitoring and coaching. Patients can have an instant, quantified assessment of their lung health, supporting decisions on rescue medication and physical exercise, whereas physicians have access to the patient’s deep pulmonary profile, enabling the optimization of the patient’s treatment.
Chronic Pulmonary Diseases affect millions of people and is currently 3rd cause of death. Despite prevalence, there is no standardized system for self-management of pulmonary health and patients often mis-medicate leading to symptom aggravation, unnecessary hospitalization and premature death. The absence of in situ monitoring, prohibits physicians to practically optimize dosage and medication type, adding a huge burden to both their pulmonary health and the economy of healthcare systems.
Respi offers a personalized management system for chronic respiratory disease, based on the patient’s smartphone. It consists of a smartphone enabled spirometer and a connected interpretive mobile application offering customized disease monitoring and coaching. Using the golden standard of pulmonology, Spirometry, Respi creates a deep patient profile to be used for optimizing medication, incentivizing patients and supporting patient and physician-side decisions.
Antonios Kouris, CEO & Founder
Nikolas Margaritis, Clinical Development Advisor